Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma
Washington University School of Medicine
Washington University School of Medicine
Gilead Sciences
University of Chicago
BeOne Medicines
Eli Lilly and Company
Acerta Pharma BV
H. Lee Moffitt Cancer Center and Research Institute
Alliance for Clinical Trials in Oncology
Janssen Research & Development, LLC
Universität des Saarlandes
PrECOG, LLC.
Insel Gruppe AG, University Hospital Bern
University of Miami
Pharmacyclics LLC.
Celgene
AbbVie
Janssen Research & Development, LLC
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Johnson & Johnson Private Limited
Mayo Clinic
SCRI Development Innovations, LLC
Thomas Jefferson University
Incyte Corporation
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Oncternal Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
AstraZeneca
AstraZeneca
Dana-Farber Cancer Institute
BeiGene
Stanford University
Pfizer
Memorial Sloan Kettering Cancer Center
University of Miami
Weill Medical College of Cornell University
City of Hope Medical Center
Northwestern University
City of Hope Medical Center
City of Hope Medical Center
Roswell Park Cancer Institute
PrECOG, LLC.
City of Hope Medical Center
Celgene
University of Nebraska
University of Nebraska
Vanderbilt-Ingram Cancer Center
University of Nebraska